abagovomab 30
abciximab 30
abituzumab 24
abrilumab 23
actoxumab 18
adalimumab 21
aducanumab 14
afasevikumab 17
alacizumab_pegol 12
alemtuzumab 31
alirocumab 23
amatuximab 45
andecaliximab 23
anifrolumab 22
anrukinzumab 20
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 25
ascrinvacumab 8
atezolizumab 16
atinumab 16
avelumab 15
basiliximab 31
bavituximab 41
begelomab 28
benralizumab 31
bevacizumab_beta 22
bezlotoxumab 18
bimagrumab 22
bleselumab 17
blinatumomab 33
blosozumab 30
bococizumab 21
brazikumab 18
brentuximab_vedotin 36
briakinumab 19
brodalumab 14
brolucizumab 28
brontictuzumab 29
burosumab 22
cabiralizumab 30
camrelizumab 15
canakinumab 23
cantuzumab_ravtansin 49
carlumab 15
carotuximab 29
cergutuzumab_amunaleukin2 28
cergutuzumab_amunaleukin 28
certolizumab_pegol 27
cetiximab 47
citatuzumab_bogatox 30
cixutumumab 29
clivatuzumab_tetraxetan 26
codrituzumab 32
conatumumab 14
concizumab 29
crenezumab 22
crizanlizumab 28
crotedumab 21
dacetuzumab 26
daclizumab 21
dalotuzumab 36
dapirolizumab_pegol 28
daratumumab 14
dectrekumab 10
demcizumab 28
denosumab 10
depatuxizumab 29
depatuxizumab_mafodotin 29
dezamizumab 25
dinutuximab 42
diridavumab 26
domagrozumab 17
drozitumab 18
duligotuzumab 21
durvalumab 12
dusigitumab 21
efalizumab 36
efungumab 31
eldelumab 17
elezanumab 25
elgemtumab 14
elotuzumab 19
emactuzumab 22
emapalumab 28
emibetuzumab 20
enavatuzumab 25
enfortumab_vedotin 15
enoblituzumab 21
enokizumab 25
enoticumab 20
ensituximab 39
eptinezumab 19
erenumab 23
etaracizumab 15
etrolizumab 24
evinacumab 23
evolocumab 20
farletuzumab 8
fasinumab 27
fezakinumab 25
fibatuzumab 13
ficlatuzumab 26
firivumab 37
flanvotumab 23
fletikumab 24
foralumab 14
foravirumab 16
fremanezumab 29
fresolimumab 19
fulranumab 20
futuximab 29
galcanezumab 22
ganitumab 31
gantenerumab 14
gemetuzumab 35
gemtuzumab2 28
gemtuzumab 28
gevokizumab 24
girentuximab 29
glembatumumab 21
glembatumumab_vedotin 21
guselkumab 23
ibalizumab 30
ibritumomab 42
icrucumab 12
idarucizumab 36
ifabotuzumab 13
imalumab 19
imgatuzumab 24
inclacumab 21
indatuximab_ravtansin 37
indusatumab 21
inebilizumab 25
intetumumab 14
iodine_girentuximab 30
ipilimumab 7
iratumumab 15
isatuximab 38
itolizumab 27
ixekizumab 33
labetuzumab_govitecan 25
lambrolizumab 28
lampalizumab 28
lanadelumab 19
landogrozumab 19
laprituximab 31
lebrikizumab 41
lendalizumab 27
lenzilumab 20
lifastuzumab_vedotin 26
ligelizumab 23
lilotomab 41
lirilumab 25
lodelcizumab 20
lokivetmab 25
lorvotuzumab_mertansin 26
lucatumumab 31
lumretuzumab 22
lupartumab 17
lutikizumab 21
margetuximab 36
milatuzumab 41
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 42
mogamulizumab 31
monalizumab 23
motavizumab 39
moxetumomab_pasudotox 32
namilumab 26
naratuximab 33
naratuximab_emtansin 33
narnatumab 16
navicixizumab2 29
navicixizumab 29
navivumab 35
necitumumab 12
nemolizumab 31
nesvacumab 18
nivolumab 13
obiltoxaximab 25
obinutuzumab 36
ocaratuzumab 29
ofatumumab 20
olaratumab 19
olokizumab 26
omalizumab 22
onartuzumab 24
ontuxizumab 34
opicinumab 15
orticumab 16
otelixizumab 38
oxelumab 13
ozanezumab 35
pamrevlumab 13
panobacumab 31
parsatuzumab 29
pasotuxizumab 23
pateclizumab 21
patritumab 24
pembrolizumab 28
perakizumab 25
pidilizumab 22
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 27
polatuzumab_vedotin 22
ponezumab 40
prezalumab 16
pritoxaximab 42
quilizumab 21
racotumomab 32
radretumab 16
ralpancizumab 23
ramucirumab 14
ranevetmab 31
ranibizumab 25
refanezumab 24
remtolumab 21
rilotumumab 15
rinucumab 20
risankizumab 34
rituximab 26
rivabazumab 23
robatumumab 20
roledumab 35
romosozumab 25
rontalizumab 25
rosmantuzumab 25
rozanolixizumab 22
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 29
sapelizumab 24
sarilumab 18
secukinumab 15
seribantumab 18
setoxaximab 49
sifalimumab 14
siltuximab 25
simtuzumab 31
sirukumab 12
solanezumab 27
solitomab 33
stamulumab 20
suptavumab 22
suvizumab 21
tabalumab 15
tadocizumab 22
tamtuvetmab 37
tanezumab 23
tarextumab 13
tavolixizumab 19
telisotuzumab 32
teplizumab 24
tesidolumab 24
tezepelumab 25
tigatuzumab 18
tildrakizumab 23
timolumab 17
tisotumab 15
tosatoxumab 42
tositumomab 39
tralokinumab 27
trastuzumab 24
tregalizumab 24
trevogrumab 14
ublituximab 32
urelumab 22
ustekinumab 30
utomilumab 28
vadastuximab 29
vadastuximab_talirin 29
vandortuzumab_vedotin 22
vantictumab 20
vanucizumab2 22
vanucizumab 31
varlilumab 17
vatelizumab 23
vedolizumab 30
veltuzumab 19
vesencumab 12
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 33
xentuzumab 21
zatuximab 42
